Nasal polyps are soft, noncancerous growths on the lining of the nose or sinuses. These growths, while painless, can cause blockages that prevent the sinuses from draining properly. This can make it ...

The nose is the subject of many sayings. A measurement could be on the nose or an object right under your nose. You may be reminded to keep your nose clean and out of another’s affairs. While often ...

Q: My son has been dealing with chronic sinusitis for years. He thinks that he might have nasal polyps. Can you tell me about this? A: Nasal polyps are soft, painless growths that form in the nasal ...

Spring allergy season can be a double problem for some people. On top of allergies, they also have blocked sinuses, and surgery may be the only path to relief. Allergy sufferers are most at risk of ...

POPS is a breakthrough in the assessment of chronic rhinosinusitis with nasal polyposis. It allows us to better document the severity of polyps in the postoperative sinus cavity.” — Thomas S. Higgins, ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

Nasal polyp development, treatment, and recurrence were topics up for discussion in this year’s most popular nasal polyps–related content. Nasal polyp development, treatment, and recurrence, as well ...

The Family Health Care Institute bulletin (one of King Hussein Foundation's institutes), on this Sunday, discusses nasal and ...

Antrochoanal polyps (ACPs) are benign, solitary lesions that originate from the mucosa of the maxillary sinus and extend into the nasal cavity towards the choana. They can present with unilateral ...

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years ...

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...